MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202611102045 A) filed by Dr. Vijayakumar M. R. on August 24, 2026, for Gefitinib And Betulin-Loaded Asgpr-Targeted Liposomes Against Hepatocellular Carcinoma.
Inventors include Dr. Vijayakumar M. R.; and Amita Singh.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: Hepatocellular carcinoma (HCC) is difficult to treat, and gefitinib monotherapy may offer limited therapeutic benefits. Combination or multimodal approaches are often required to achieve therapeutic efficacy in such cases. Betulin, a naturally occurring triterpene, is used in combination with gefitinib to enhance therapeutic efficacy agai...